HPGC(SH:600664) Shang Hai Zheng Quan Bao·2025-08-04 19:35Core Viewpoint - Harbin Pharmaceutical Group Co., Ltd. plans to lease out part of its idle assets located at 109 Xuefu Road, Harbin, to enhance asset utilization and generate stable rental income, which is expected to positively impact the company's financial status [5][14]. Group 1: Board Meeting and Decision - The company's board of directors held its sixteenth meeting on August 4, 2025, where it unanimously approved the proposal to lease out idle assets [1][4]. - The decision to lease was based on a previous resolution from the thirteenth board meeting on April 25, 2025, aimed at revitalizing idle assets and improving asset efficiency [2][6]. Group 2: Asset Details - The assets to be leased include 10 buildings with a total area of 22,671.39 square meters, part of the Harbin Pharmaceutical Group's manufacturing facility [9]. - The leased properties are free from any ownership disputes or legal encumbrances, ensuring a clear title for the leasing process [9]. Group 3: Leasing Terms - The lease term is set for 10 years, including a rent-free period of 60 to 180 days for renovations, with rental fees to be borne by the lessee [10][11]. - Rental prices will be based on a market assessment report, with specific annual increases outlined for the subsequent years [11][12]. Group 4: Impact on Company - The leasing of idle assets is expected to improve asset utilization and provide a stable income stream, contributing positively to the company's future financial health [14]. - The leasing process will follow a market-oriented approach, ensuring fairness and transparency in the selection of tenants [8].